Skip to Content

← See all Sennosides brands

Sennosides by New World Imports, Inc

Medically reviewed on March 26, 2018

Dosage form: tablet
Ingredients: sennosides a and b 8.6mg
Labeler: New World Imports, Inc
NDC Code: 51824-217

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Facts



In case of accidental overdose, contact a doctor or Poison Control Center immediately.

For relief of occasional constipation and irregularity.

This product produces a bowel movement in 6 to 12 hours.

Do not use laxative products when abdominal pain, nausea, or vomiting are present unless directed by a doctor.

Ask a doctor before use if you have a sudden change in bowel habits that persists over a period of 2 weeks.

Ask a doctor or pharmacist before use if you are taking a prescription drug.  Laxatives may affect how other drugs work.  Take this product 2 or more hours before or after other drugs.

When using this product do not use for longer than 1 week unless directed by a doctor

Stop use and ask a doctor if rectal bleeding or failure to have a bowel movement occur after use of a laxative.  These could be signs of a serious condition.

If Pregnant or breast-feeding ask a health professional before use.

Take preferably at bedtime or as directed by a doctor.  If you do not have comfortable bowel movement by the second day, increase dose by one tablet (do not exceed the maximum dosage) or decrease dose until you are comfortable.

Adults and children over 12 years: 2 tablets once a day.  Maximum of 4 tablets twice a day.

Children 6 to under 12 years: 1 tablet once a day.  Maximum of 2 tablets twice a day.

Children 2 to under 6 years: 1/2 tablet once a day.  Maximum of 1 tablet twice a day.

Children under 2: consult a doctor

Colloidal silicon dioxide, croscarmellose sodium, dibasic dicalcium phosphate dihydrate, lactose, magnesium stearate, microcrystalline cellulose, and tartaric acid.

sennosides tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51824-217
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
sennosides a and b (SENNOSIDES A AND B) sennosides a and b8.6 mg
Inactive Ingredients
Ingredient NameStrength
Colloidal silicon dioxide 
Croscarmellose Sodium 
Magnesium stearate 
Cellulose, microcrystalline 
Product Characteristics
Colorbrown (Speckled various shades of brown) Scoreno score
ShapeROUND (Round) Size8mm
FlavorImprint CodeAZ;217
#Item CodePackage Description
1NDC:51824-217-01100 TABLET (TABLET) in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33409/10/2010
Labeler - New World Imports, Inc (075372276)
Allegiant Health079501930manufacture(51824-217)

New World Imports, Inc

← See all Sennosides brands

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.